YOUR HEALTH MATTERS

RESEARCH, IN PERSPECTIVE

lets talk health

Research, in perspective.

Mediterranean Diet Improved Lipids; Fasting-Linked Weight Loss Lowered Inflammation

Mediterranean-style meal with vegetables and olive oil on a table

A small controlled trial suggests that a Mediterranean-style diet improved cholesterol measures, while lower inflammation appeared only after twice-weekly fasting was added and participants lost more weight. The result separates two changes that often happen together—but it does not prove fasting is necessary for everyone.

What changed

Researchers randomly assigned 53 adults with metabolic risk factors (77% women; average age 54.7) to a fully provided Mediterranean diet or their usual Western diet. After eight weeks, both groups added two fasting days per week for another eight weeks. The Mediterranean diet improved blood lipids during the diet-only phase, but the primary outcome—high-sensitivity C-reactive protein, a blood marker of inflammation—did not change. After fasting began, the Mediterranean-diet group had a larger fall in that marker, alongside greater weight loss, better insulin sensitivity, and lower blood pressure. The peer-reviewed paper was published October 21, 2026, and publicly reported October 22.

How strong is the evidence?

This was a 16-week human randomized controlled-feeding trial, stronger than an observational diet study. However, it was small, and the fasting phase was added after the diet phase rather than tested as a separate randomized comparison. The authors reported no competing interests.

What remains uncertain

Because fasting and weight loss occurred together, the study cannot cleanly identify which caused the inflammation change. C-reactive protein, blood pressure, and insulin sensitivity are surrogate markers—not proof of fewer heart attacks or longer life. Longer, larger trials are needed.

Why it matters

The practical takeaway is modest: Mediterranean-style food choices may improve lipids even before weight loss, while reducing inflammation may depend more on sustained energy balance and weight change. People using diabetes or blood-pressure medicines should discuss fasting with a clinician rather than copying the trial.

Related: Heart-risk warning signs can appear before diabetes is diagnosed.

Sources

Original study in Cell Metabolism; PubMed record and abstract; public research report.

Illustrative stock photograph by jevgeni mironov on Unsplash; it does not depict trial participants, the study meals, or results.